Literature DB >> 8135684

Emotional lability after stroke.

P L Morris1, R G Robinson, B Raphael.   

Abstract

The aims of this study were (i) to determine the frequency of emotional lability following first ever stroke, and (ii) to identify factors associated with this condition. Sixty-six consecutive inpatients with first ever stroke were surveyed two months post stroke for the presence of emotional lability. Demographic, clinical, psychiatric and stroke lesion characteristics were also assessed. Emotional lability was present in 12 of the 66 patients (prevalence: 18%). Emotional lability occurred independently of post stroke depression. Single lesions located in anterior regions of the cerebral hemispheres had four times the odds of emotional lability than lesions located anywhere else (p < 0.05). Emotional lability is a common emotional-behavioural syndrome following stroke and is probably a separate condition from post stroke depression. The aetiology of this condition is possibly related to the consequences of injury to anterior regions of the cerebral hemispheres.

Entities:  

Mesh:

Year:  1993        PMID: 8135684     DOI: 10.3109/00048679309075822

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  14 in total

1.  Randomized open-label drug-drug interaction trial of dextromethorphan/quinidine and paroxetine in healthy volunteers.

Authors:  Kerri A Schoedel; Laura E Pope; Edward M Sellers
Journal:  Clin Drug Investig       Date:  2012-03-01       Impact factor: 2.859

2.  A self report measure of affective lability.

Authors:  S R Moore; L S Gresham; M B Bromberg; E J Kasarkis; R A Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

Review 3.  Poststroke depression: prevalence, course, and associated factors.

Authors:  S G Hosking; N V Marsh; P J Friedman
Journal:  Neuropsychol Rev       Date:  1996-09       Impact factor: 7.444

4.  Emotional incontinence in Chinese stroke patients--diagnosis, frequency, and clinical and radiological correlates.

Authors:  Wai Kwong Tang; Sandra S M Chan; Helen F K Chiu; Gabor S Ungvari; Ka Sing Wong; Timothy C Y Kwok
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

5.  A metabonomic investigation on the biochemical perturbation in post-stroke patients with depressive disorder (PSD).

Authors:  Xinghua Ding; Ruoxu Liu; Wenkai Li; Hengjia Ni; Yong Liu; Dandan Wu; Shuguang Yang; Jing Liu; Bo Xiao; Shaojun Liu
Journal:  Metab Brain Dis       Date:  2015-11-05       Impact factor: 3.584

6.  Effective use of sertraline for pathological laughing after severe vasospasm due to aneurysmal subarachnoid hemorrhage: case report.

Authors:  Hayato Takeuchi; Kazuhide Iwamoto; Mao Mukai; Tomoaki Fujita; Hitoshi Tsujino; Yoshihiro Iwamoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2013-11-08       Impact factor: 1.742

7.  PRISM: a novel research tool to assess the prevalence of pseudobulbar affect symptoms across neurological conditions.

Authors:  Benjamin Rix Brooks; David Crumpacker; Jonathan Fellus; Daniel Kantor; Randall E Kaye
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

8.  PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.

Authors:  Flora M Hammond; David N Alexander; Andrew J Cutler; Stephen D'Amico; Rachelle S Doody; William Sauve; Richard D Zorowitz; Charles S Davis; Paul Shin; Fred Ledon; Charles Yonan; Andrea E Formella; Joao Siffert
Journal:  BMC Neurol       Date:  2016-06-09       Impact factor: 2.474

Review 9.  Pseudobulbar affect: prevalence and management.

Authors:  Aiesha Ahmed; Zachary Simmons
Journal:  Ther Clin Risk Manag       Date:  2013-11-29       Impact factor: 2.423

10.  Psychiatric comorbidity and quality of life in patients with post-stroke emotional incontinence.

Authors:  Dong-Ho Choi; Bo-Ok Jeong; Hee-Ju Kang; Sung-Wan Kim; Jae-Min Kim; Il-Seon Shin; Joon-Tae Kim; Man-Seok Park; Ki-Hyun Cho; Jin-Sang Yoon
Journal:  Psychiatry Investig       Date:  2013-10-16       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.